Lucia Lisa Petrilli

Dr. Lucia Lisa Petrilli

Department of Onco-hematology, Gene and Cell Therapy—Bambino Gesù Children’s Hospital
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2015 in Nucleic Acids Research
Verified
Journal Article
Open access
LPLivia Perfetto
Livia Perfetto
LBLeonardo Briganti
Leonardo Briganti
ACAlberto Calderone
Alberto Calderone
APAndrea Cerquone Perpetuini
Andrea Cerquone Perpetuini
MIMarta Iannuccelli
Marta Iannuccelli
GCGianni Cesareni
Gianni Cesareni
Assembly of large biochemical networks can be achieved by confronting new cell-specific experimental data with an interaction subspace constrained by prior literature evidence. The SIGnaling Network Open Resource, SIGNOR (available on line at http://signor.uniroma2.it), was developed to support such a strategy by providing a scaffold of prior experimental evidence of causal relationships between biological entities. The core of SIGNOR is a collection of approximately 12,000 manually-annotated causal relationships between over 2800 human proteins participating in signal transduction. Other entities annotated in SIGNOR are complexes, chemicals, phenotypes and stimuli. The information captured in SIGNOR can be represented as a signed directed graph illustrating the activation/inactivation relationships between signalling entities. Each entry is associated to the post-translational modifications that cause the activation/inactivation of the target proteins. More than 4900 modified residues causing a change in protein concentration or activity have been curated and linked to the modifying enzymes (about 351 human kinases and 94 phosphatases). Additional modifications such as ubiquitinations, sumoylations, acetylations and their effect on the modified target proteins are also annotated. This wealth of structured information can support experimental approaches based on multi-parametric analysis of cell systems after physiological or pathological perturbations and to assemble large logic models.

7 May 2020 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
ARAlessio Reggio
Alessio Reggio
MRMarco Rosina
Marco Rosina
APAlessandro Palma
Alessandro Palma
APAndrea Cerquone Perpetuini
Andrea Cerquone Perpetuini
LPLucia Lisa Petrilli
Lucia Lisa Petrilli
GCGianni Cesareni
Gianni Cesareni

25 June 2019 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
MMMilica Marinkovic
Milica Marinkovic
CFClaudia Fuoco
Claudia Fuoco
FSFrancesca Sacco
Francesca Sacco
APAndrea Cerquone Perpetuini
Andrea Cerquone Perpetuini
GGGiulio Giuliani
Giulio Giuliani
GCGianni Cesareni
Gianni Cesareni
Fibro-adipogenic progenitors (FAPs) promote satellite cell differentiation in adult skeletal muscle regeneration. However, in pathological conditions, FAPs are responsible for fibrosis and fatty infiltrations. Here we show that the NOTCH pathway negatively modulates FAP differentiation both in vitro and in vivo. However, FAPs isolated from young dystrophin-deficient mdx mice are insensitive to this control mechanism. An unbiased mass spectrometry–based proteomic analysis of FAPs from muscles of wild-type and mdx mice suggested that the synergistic cooperation between NOTCH and inflammatory signals controls FAP differentiation. Remarkably, we demonstrated that factors released by hematopoietic cells restore the sensitivity to NOTCH adipogenic inhibition in mdx FAPs. These results offer a basis for rationalizing pathological ectopic fat infiltrations in skeletal muscle and may suggest new therapeutic strategies to mitigate the detrimental effects of fat depositions in muscles of dystrophic patients.

4 February 2020 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
ARAlessio Reggio
Alessio Reggio
MRMarco Rosina
Marco Rosina
NKNatalie Krahmer
Natalie Krahmer
APAlessandro Palma
Alessandro Palma
LPLucia Lisa Petrilli
Lucia Lisa Petrilli
FSFrancesca Sacco
Francesca Sacco
In Duchenne muscular dystrophy (DMD), the absence of the dystrophin protein causes a variety of poorly understood secondary effects. Notably, muscle fibers of dystrophic individuals are characterized by mitochondrial dysfunctions, as revealed by a reduced ATP production rate and by defective oxidative phosphorylation. Here, we show that in a mouse model of DMD (mdx), fibro/adipogenic progenitors (FAPs) are characterized by a dysfunctional mitochondrial metabolism which correlates with increased adipogenic potential. Using high-sensitivity mass spectrometry–based proteomics, we report that a short-term high-fat diet (HFD) reprograms dystrophic FAP metabolism in vivo. By combining our proteomic dataset with a literature-derived signaling network, we revealed that HFD modulates the β-catenin–follistatin axis. These changes are accompanied by significant amelioration of the histological phenotype in dystrophic mice. Transplantation of purified FAPs from HFD-fed mice into the muscles of dystrophic recipients demonstrates that modulation of FAP metabolism can be functional to ameliorate the dystrophic phenotype. Our study supports metabolic reprogramming of muscle interstitial progenitor cells as a novel approach to alleviate some of the adverse outcomes of DMD.

27 July 2016 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
CFClaudia Fuoco
Claudia Fuoco
LPLucia Lisa Petrilli
Lucia Lisa Petrilli
SCStefano Cannata
Stefano Cannata
CGCesare Gargioli
Cesare Gargioli
Extracellular matrix (ECM) is composed of many types of fibrous structural proteins and glycosaminoglycans. This important cell component not only provides a support for cells but is also actively involved in cell-cell interaction, proliferation, migration, and differentiation, representing, therefore, no longer only a mere static structural scaffold for cells but rather a dynamic and versatile compartment. This aspect leads to the need for investigating new bio-inspired scaffolds or biomaterials, able to mimic ECM in tissue engineering. This new field of research finds particular employment in skeletal muscle tissue regeneration, due to the inability of this complex tissue to recover volumetric muscle loss (VML), after severe injury. Usually, this is the result of traumatic incidents, tumor ablations, or pathological states that lead to the destruction of a large amount of tissue, including connective tissue and basement membrane. Therefore, skeletal muscle tissue engineering represents a valid alternative to overcome this problem. Here, we described a series of natural and synthetic biomaterials employed as ECM mimics for their ability to recreate the correct muscle stem cell niche, by promoting myogenic stem cell differentiation and so, positively affecting muscle repair.

7 May 2021 in Journal for ImmunoTherapy of Cancer
Verified
Journal Article
Open access
PDF file
CAClaudia Manuela Arnone
Claudia Manuela Arnone
VPVinicia Assunta Polito
Vinicia Assunta Polito
AMAngela Mastronuzzi
Angela Mastronuzzi
ACAndrea Carai
Andrea Carai
FDFrancesca Camassei Diomedi
Francesca Camassei Diomedi
FBFrancesca Del Bufalo
Francesca Del Bufalo
Background Pediatric high-grade gliomas (pHGGs) are among the most common and incurable malignant neoplasms of childhood. Despite aggressive, multimodal treatment, the outcome of children with high-grade gliomas has not significantly improved over the past decades, prompting the development of innovative approaches. Methods To develop an effective treatment, we aimed at improving the suboptimal antitumor efficacy of oncolytic adenoviruses (OAs) by testing the combination with a gene-therapy approach using a bispecific T-cell engager (BiTE) directed towards the erythropoietin-producing human hepatocellular carcinoma A2 receptor (EphA2), conveyed by a replication-incompetent adenoviral vector (EphA2 adenovirus (EAd)). The combinatorial approach was tested in vitro, in vivo and thoroughly characterized at a molecular level. Results After confirming the relevance of EphA2 as target in pHGGs, documenting a significant correlation with worse clinical outcome of the patients, we showed that the proposed strategy provides significant EphA2-BiTE amplification and enhanced tumor cell apoptosis, on coculture with T cells. Moreover, T-cell activation through an agonistic anti-CD28 antibody further increased the activation/proliferation profiles and functional response against infected tumor cells, inducing eradication of highly resistant, primary pHGG cells. The gene-expression analysis of tumor cells and T cells, after coculture, revealed the importance of both EphA2-BiTE and costimulation in the proposed system. These in vitro observations translated into significant tumor control in vivo, in both subcutaneous and a more challenging orthotopic model. Conclusions The combination of OA and EphA2-BiTE gene therapy strongly enhances the antitumor activity of OA, inducing the eradication of highly resistant tumor cells, thus supporting the clinical translation of the approach.